Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

BCL-2 inhibitor TQB3909 combined with JAK inhibitors in patients with intermediate- or high-risk myelofibrosis: A two-cohort, open-label, Phase ib/II, multicenter study

Jian Huang, Tian Zeng, Xiudi Yang, Xingli Zhao, Guangxun Gao, Hu Zhou, Hongyan Tong

Blood (2025) 146 (Supplement 1): 2034.

https://doi.org/10.1182/blood-2025-2034

Published: 2025

Journal Articles

Genome-wide CRISPR-Cas9 screen reveals novel ruxolitinib-resistance targets in myeloproliferative neoplasms

Qingmei Han, Rumeng Li, Bingbing Wen, Tian Zeng, Zhikang Zheng, Xiaojing Bao, Xiudi Yang, Jian Huang

Blood (2025) 146 (Supplement 1): 7286.

https://doi.org/10.1182/blood-2025-7286

Published: 2025

Journal Articles

Decitabine enhances the cytotoxic effect of ruxolitinib in myeloproliferative neoplasms by targeting SR splicing factors

Qingmei Han, Rumeng Li, Bingbing Wen, Tian Zeng, Zhikang Zheng, Xiaojing Bao, Xiudi Yang, Jian Huang

Blood (2025) 146 (Supplement 1): 7276.

https://doi.org/10.1182/blood-2025-7276

Published: 2025

Journal Articles

ASXL1 and NOTCH1 mutations independently predict TKI treatment failure in chronic myeloid leukemia

Tian Zeng, Xiudi Yang, Rumeng Li, Qingmei Han, Bingbing Wen, Zhikang Zheng, Xiaojing Bao, Jian Huang

Blood (2025) 146 (Supplement 1): 5551.

https://doi.org/10.1182/blood-2025-5551

Published: 2025

Journal Articles

A novel strategy to circumvent venetoclax resistance in relapsed/refractory Acute Myeloid Leukemia

Huafeng Wang, Yile Zhou, Xiang Zhang, Liping Mao, Xia Li, Xingnong Ye, Mixue Xie, De Zhou, Xiudi Yang, Jian Huang, Wenjuan Yu, Juying Wei, Min Yang, Yinjun Lou, Yanhong Tong, Jie Jin

Blood (2025) 146 (Supplement 1): 3464.

https://doi.org/10.1182/blood-2025-3464

Published: 2025

Journal Articles

Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China

De Zhou, Xianbo Huang, Lixia Zhu, Xuelian Hu, Xiudi Yang, Mixue Xie, Xin Huang, Fang Yu, Juying Wei, Liya Ma, Jingjing Zhu, Shuqi Zhao, Wanzhuo Xie, Hongyan Tong, Jie Jin, Xiujin Ye

Blood (2025) 146 (3): 318–327.

https://doi.org/10.1182/blood.2024026139

Published: 2025

Includes: Supplemental data

Journal Articles

Comparing the Clinical and Genetic Features By Next-Generation Sequencing and RNA Sequencing of Polycythemia Vera and Post-Polycythemia Vera Myelofibrosis Patients

Lingrong Tu, Xiudi Yang, Xiaoqiong Zhu, Ying Lu, Honglan Qian, Jian Huang

Blood (2024) 144 (Supplement 1): 6637.

https://doi.org/10.1182/blood-2024-205374

Published: 2024

Journal Articles

A Prognostic Model Guiding Treatment Switch for 5-Year Deep Molecular Response in Chronic Myeloid Leukemia Patients Receiving Initial Imatinib: An Extensive, Multi-Center, Retrospective Study

Tian Zeng, Xiudi Yang, Yi Wang, Dijiong Wu, Weiying Feng, Ying Lu, Huafeng Wang, Jian Huang

Blood (2024) 144 (Supplement 1): 1770.

https://doi.org/10.1182/blood-2024-204525

Published: 2024

Journal Articles

A Nomogram for Predicting T315I-Free Survival in Chronic Phase Chronic Myeloid Leukemia Patients: A Multi-Center Retrospective Study

Shiwei Hu, Xiudi Yang, Dijiong Wu, Yi Wang, Xiaoqiong Zhu, Weiying Feng, Huafeng Wang, Jian Huang

Blood (2024) 144 (Supplement 1): 1769.

https://doi.org/10.1182/blood-2024-203703

Published: 2024

Journal Articles

A Predictive Model for Progression to Overt Primary Myelofibrosis in Early/Prefibrotic Primary Myelofibrosis Patients

Shiwei Hu, Xiudi Yang, Xiaoqiong Zhu, Honglan Qian, Ying Lu, Yanxia Han, Huafeng Wang, Jian Huang

Blood (2024) 144 (Supplement 1): 1782.

https://doi.org/10.1182/blood-2024-204773

Published: 2024

Journal Articles

Comparing the Efficacy and Safety of Ruxolitinib in Patients with Lower and Higher Risk Myelofibrosis: A Multi-Center, Single-Arm, Exploratory and Prospective Study

Shiwei Hu, Xiudi Yang, Ying Lu, Gang Zhang, Xianghua Lang, Li Huang, Jian Huang

Blood (2024) 144 (Supplement 1): 1786.

https://doi.org/10.1182/blood-2024-205090

Published: 2024

Journal Articles

Mean Corpuscular Hemoglobin Optimizes the Thrombocytosis Risk Stratification in Polycythemia Vera: A Retrospective Multi-Center Study

Danhong Xiang, Xiudi Yang, Shiwei Hu, Jian Huang

Blood (2023) 142 (Supplement 1): 6427.

https://doi.org/10.1182/blood-2023-185468

Published: 2023

Journal Articles

Comparison of Characteristics of Chronic Myeloid Leukemia Combined with Different Degrees of Myelofibrosis : A Real-World Multicenter Retrospective Study from China

Xinlu Zhang, Xiudi Yang, Jingjing Zhu, Jian Huang

Blood (2023) 142 (Supplement 1): 6357.

https://doi.org/10.1182/blood-2023-184875

Published: 2023

Journal Articles

Internal and External Validation of the Predictive Scoring Systems from Essential Thrombocythemia to Post-ET Myelofibrosis

Danhong Xiang, Xiudi Yang, Jingjing Zhu, Jian Huang

Blood (2023) 142 (Supplement 1): 6424.

https://doi.org/10.1182/blood-2023-184890

Published: 2023

Journal Articles

Clinical and Genetic Features By Next-Generation Sequencing and RNA Sequencing in Pre-Fibrotic Primary Myelofibrosis Patients

Shiwei Hu, Xiudi Yang, Jingjing Zhu, Jian Huang

Blood (2023) 142 (Supplement 1): 1836.

https://doi.org/10.1182/blood-2023-182703

Published: 2023

Journal Articles

Ruxolitinib Combined with Dexamethasone in Adult Patients with Newly Diagnosed Hemophagocytic Lymphohistiocytosis: A Prospective, Single-Center, Single-Arm, Phase 2 Clinical Trial

De Zhou, Xianbo Huang, Xueying Li, Lixia Zhu, Mixue Xie, Xin Huang, Fang Yu, Juying Wei, Liya Ma, Xiudi Yang, Jianai Sun, Li Li, Wanzhuo Xie, Hongyan Tong, Jie Jin, Honghu Zhu, Xiujin Ye

Blood (2022) 140 (Supplement 1): 2620–2621.

https://doi.org/10.1182/blood-2022-164496

Published: 2022

Journal Articles

Decreased Expression of Telomere Length Regulating Factors TRF1, and Tankyrase 1 in Patients with Adult Acute Leukemia.

Wenbin Qian, Xiudi Yang, Weilai Xu

Blood (2006) 108 (11): 4421.

https://doi.org/10.1182/blood.V108.11.4421.4421

Published: 2006

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

BCL-2 inhibitor TQB3909 combined with JAK inhibitors in patients with intermediate- or high-risk myelofibrosis: A two-cohort, open-label, Phase ib/II, multicenter study

Genome-wide CRISPR-Cas9 screen reveals novel ruxolitinib-resistance targets in myeloproliferative neoplasms

Decitabine enhances the cytotoxic effect of ruxolitinib in myeloproliferative neoplasms by targeting SR splicing factors

ASXL1 and NOTCH1 mutations independently predict TKI treatment failure in chronic myeloid leukemia

A novel strategy to circumvent venetoclax resistance in relapsed/refractory Acute Myeloid Leukemia

Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China

Comparing the Clinical and Genetic Features By Next-Generation Sequencing and RNA Sequencing of Polycythemia Vera and Post-Polycythemia Vera Myelofibrosis Patients

A Prognostic Model Guiding Treatment Switch for 5-Year Deep Molecular Response in Chronic Myeloid Leukemia Patients Receiving Initial Imatinib: An Extensive, Multi-Center, Retrospective Study

A Nomogram for Predicting T315I-Free Survival in Chronic Phase Chronic Myeloid Leukemia Patients: A Multi-Center Retrospective Study

A Predictive Model for Progression to Overt Primary Myelofibrosis in Early/Prefibrotic Primary Myelofibrosis Patients

Comparing the Efficacy and Safety of Ruxolitinib in Patients with Lower and Higher Risk Myelofibrosis: A Multi-Center, Single-Arm, Exploratory and Prospective Study

Mean Corpuscular Hemoglobin Optimizes the Thrombocytosis Risk Stratification in Polycythemia Vera: A Retrospective Multi-Center Study

Comparison of Characteristics of Chronic Myeloid Leukemia Combined with Different Degrees of Myelofibrosis : A Real-World Multicenter Retrospective Study from China

Internal and External Validation of the Predictive Scoring Systems from Essential Thrombocythemia to Post-ET Myelofibrosis

Clinical and Genetic Features By Next-Generation Sequencing and RNA Sequencing in Pre-Fibrotic Primary Myelofibrosis Patients

Ruxolitinib Combined with Dexamethasone in Adult Patients with Newly Diagnosed Hemophagocytic Lymphohistiocytosis: A Prospective, Single-Center, Single-Arm, Phase 2 Clinical Trial

Decreased Expression of Telomere Length Regulating Factors TRF1, and Tankyrase 1 in Patients with Adult Acute Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only